Ernexa Therapeutics Inc. Payments to Develop Software
Ernexa Therapeutics Inc. (ERNA) reported Payments to Develop Software of $203.00 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-11.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:PaymentsToDevelopSoftware · last filed 2018-05-11
- Ernexa Therapeutics Inc. payments to develop software for the quarter ending 2018-03-31 was $203.00K, a 33.55% increase year-over-year.
- Ernexa Therapeutics Inc. payments to develop software for the quarter ending 2017-12-31 was $168.00K, a 380.00% increase year-over-year.
- Ernexa Therapeutics Inc. payments to develop software for the quarter ending 2017-09-30 was $194.00K, a 4.43% decline year-over-year.
- Ernexa Therapeutics Inc. payments to develop software for the quarter ending 2017-06-30 was $210.00K, a 176.32% increase year-over-year.
- Ernexa Therapeutics Inc. payments to develop software for fiscal 2017 was $724.00K, a 75.30% increase from fiscal 2016.
- Ernexa Therapeutics Inc. payments to develop software for fiscal 2016 was $413.00K, a 35.57% decline from fiscal 2015.
- Ernexa Therapeutics Inc. payments to develop software for fiscal 2015 was $641.00K, a 30.02% decline from fiscal 2014.
- Ernexa Therapeutics Inc. payments to develop software for fiscal 2014 was $916.00K, a 42.32% decline from fiscal 2013.
| Period end | Payments to Develop Software 3 month | Payments to Develop Software 6 month | Payments to Develop Software 9 month | Payments to Develop Software 12 month |
|---|---|---|---|---|
| 2018-03-31 | $203.00K 10-Q · filed 2018-05-11 | $371.00K derived: sum of 2 quarters · filed 2018-05-11 | $565.00K derived: sum of 3 quarters · filed 2018-05-11 | $775.00K derived: sum of 4 quarters · filed 2018-05-11 |
| 2017-12-31 | $168.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $362.00K derived: sum of 2 quarters · filed 2018-03-09 | $572.00K derived: sum of 3 quarters · filed 2018-03-09 | $724.00K 10-K · filed 2018-03-09 |
| 2017-09-30 | $194.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $404.00K derived: sum of 2 quarters · filed 2017-11-08 | $556.00K 10-Q · filed 2017-11-08 | $591.00K derived: sum of 4 quarters · filed 2018-05-11 |
| 2017-06-30 | $210.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $362.00K 10-Q · filed 2017-08-04 | $397.00K derived: sum of 3 quarters · filed 2018-05-11 | $600.00K derived: sum of 4 quarters · filed 2018-05-11 |
| 2017-03-31 | $152.00K 10-Q · filed 2018-05-11 | $187.00K derived: sum of 2 quarters · filed 2018-05-11 | $390.00K derived: sum of 3 quarters · filed 2018-05-11 | $466.00K derived: sum of 4 quarters · filed 2018-05-11 |
| 2016-12-31 | $35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $238.00K derived: sum of 2 quarters · filed 2018-03-09 | $314.00K derived: sum of 3 quarters · filed 2018-03-09 | $413.00K 10-K · filed 2018-03-09 |
| 2016-09-30 | $203.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $279.00K derived: sum of 2 quarters · filed 2017-11-08 | $378.00K 10-Q · filed 2017-11-08 | $499.00K derived: sum of 4 quarters · filed 2017-11-08 |
| 2016-06-30 | $76.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $175.00K 10-Q · filed 2017-08-04 | $296.00K derived: sum of 3 quarters · filed 2017-08-04 | $437.00K derived: sum of 4 quarters · filed 2017-08-04 |
| 2016-03-31 | $99.00K 10-Q · filed 2017-05-04 | $220.00K derived: sum of 2 quarters · filed 2017-05-04 | $361.00K derived: sum of 3 quarters · filed 2017-05-04 | $518.00K derived: sum of 4 quarters · filed 2017-05-04 |
| 2015-12-31 | $121.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $262.00K derived: sum of 2 quarters · filed 2017-03-09 | $419.00K derived: sum of 3 quarters · filed 2017-03-09 | $641.00K 10-K · filed 2017-03-09 |
| 2015-09-30 | $141.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $298.00K derived: sum of 2 quarters · filed 2016-11-09 | $520.00K 10-Q · filed 2016-11-09 | $829.00K derived: sum of 4 quarters · filed 2016-11-09 |
| 2015-06-30 | $157.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $379.00K 10-Q · filed 2016-08-04 | $688.00K derived: sum of 3 quarters · filed 2016-08-04 | $1.00M derived: sum of 4 quarters · filed 2016-08-04 |
| 2015-03-31 | $222.00K 10-Q · filed 2016-05-09 | $531.00K derived: sum of 2 quarters · filed 2016-05-09 | $843.00K derived: sum of 3 quarters · filed 2016-05-09 | $940.00K derived: sum of 4 quarters · filed 2016-05-09 |
| 2014-12-31 | $309.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $621.00K derived: sum of 2 quarters · filed 2016-03-15 | $718.00K derived: sum of 3 quarters · filed 2016-03-15 | $916.00K 10-K · filed 2016-03-15 |
| 2014-09-30 | $312.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $409.00K derived: sum of 2 quarters · filed 2015-11-09 | $607.00K 10-Q · filed 2015-11-09 | $973.00K derived: sum of 4 quarters · filed 2015-11-09 |
| 2014-06-30 | $97.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $295.00K 10-Q · filed 2015-08-10 | $661.00K derived: sum of 3 quarters · filed 2015-08-10 | $1.09M derived: sum of 4 quarters · filed 2015-08-10 |
| 2014-03-31 | $198.00K 10-Q · filed 2015-05-08 | $564.00K derived: sum of 2 quarters · filed 2015-05-08 | $992.00K derived: sum of 3 quarters · filed 2015-05-08 | $1.43M derived: sum of 4 quarters · filed 2015-05-08 |
| 2013-12-31 | $366.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27 | $794.00K derived: sum of 2 quarters · filed 2015-03-27 | $1.23M derived: sum of 3 quarters · filed 2015-03-27 | $1.59M 10-K · filed 2015-03-27 |
| 2013-09-30 | $428.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $861.00K derived: sum of 2 quarters · filed 2014-11-07 | $1.22M 10-Q · filed 2014-11-07 | $1.60M derived: sum of 4 quarters · filed 2014-11-07 |
| 2013-06-30 | $433.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $794.00K 10-Q · filed 2014-08-14 | $1.17M derived: sum of 3 quarters · filed 2014-08-14 | $1.52M derived: sum of 4 quarters · filed 2014-08-14 |
| 2013-03-31 | $361.00K 10-Q · filed 2014-05-15 | $741.00K derived: sum of 2 quarters · filed 2014-05-15 | $1.08M derived: sum of 3 quarters · filed 2014-05-15 | $1.50M derived: sum of 4 quarters · filed 2014-05-15 |
| 2012-12-31 | $380.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $723.00K derived: sum of 2 quarters · filed 2014-03-31 | $1.13M derived: sum of 3 quarters · filed 2014-03-31 | $1.44M 10-K · filed 2014-03-31 |
| 2012-09-30 | $343.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $754.00K derived: sum of 2 quarters · filed 2013-11-14 | $1.06M 10-Q · filed 2013-11-14 | $1.38M derived: sum of 4 quarters · filed 2013-11-14 |
| 2012-06-30 | $411.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $718.00K 10-Q · filed 2013-08-14 | $1.04M derived: sum of 3 quarters · filed 2013-08-14 | $1.34M derived: sum of 4 quarters · filed 2013-08-14 |
| 2012-03-31 | $307.00K 10-Q · filed 2013-05-13 | $627.00K derived: sum of 2 quarters · filed 2013-05-13 | $929.00K derived: sum of 3 quarters · filed 2013-05-13 | $1.19M derived: sum of 4 quarters · filed 2013-05-13 |
| 2011-12-31 | $320.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29 | $622.00K derived: sum of 2 quarters · filed 2013-03-29 | $880.00K derived: sum of 3 quarters · filed 2013-03-29 | $1.08M 10-K · filed 2013-03-29 |
| 2011-09-30 | $302.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $560.00K derived: sum of 2 quarters · filed 2012-11-09 | $760.00K 10-Q · filed 2012-11-09 | $898.00K derived: sum of 4 quarters · filed 2012-11-09 |
| 2011-06-30 | $258.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $458.00K 10-Q · filed 2012-08-14 | $596.00K derived: sum of 3 quarters · filed 2012-08-14 | $783.00K derived: sum of 4 quarters · filed 2012-08-14 |
| 2011-03-31 | $200.00K 10-Q · filed 2012-05-11 | $338.00K derived: sum of 2 quarters · filed 2012-05-11 | $525.00K derived: sum of 3 quarters · filed 2012-05-11 | |
| 2010-12-31 | $138.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $325.00K derived: sum of 2 quarters · filed 2012-03-30 | $845.00K 10-K · filed 2012-03-30 | |
| 2010-09-30 | $187.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $707.00K 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $520.00K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |